Skip to Main content Skip to Navigation
Journal articles

Is COVID-19 a New Hematologic Disease?

Abstract : SARS-CoV-2 viruses are positive single-stranded RNA viruses, whose infection can be asymptomatic or lead to the coronavirus disease 2019 (Covid-19). Covid-19 is a respiratory infection with a significant impact on the hematopoietic system and hemostasis leading to several cardiovascular complications. Hematologic consequences of this new infection allowed medical community to start new treatment approaches concerning infection going from targeted anti-inflammatory drugs to anticoagulation or stem cell therapies. A better understanding of Covid-19 pathophysiology, in particular hematological disorders, will help to choose appropriate treatment strategies.
Complete list of metadatas

Cited literature [53 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-02611228
Contributor : Myriam Bodescot <>
Submitted on : Monday, May 18, 2020 - 11:57:09 AM
Last modification on : Wednesday, August 19, 2020 - 11:19:03 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Benjamin Debuc, David M Smadja. Is COVID-19 a New Hematologic Disease?. Stem Cell Reviews and Reports, Humana Press, 2020, Epub ahead of print. ⟨10.1007/s12015-020-09987-4⟩. ⟨inserm-02611228⟩

Share

Metrics

Record views

63